Aduro Biotech Announces Pancreatic Cancer And Mesothelioma Abstracts To Be Presented At 2014 American Society of Clinical Oncology Annual Meeting

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Aduro BioTech, Inc., a clinical stage biotechnology company, today announced that two posters highlighting clinical trials of the company’s pancreatic cancer and mesothelioma immunotherapies will be presented at the upcoming American Society of Clinical Oncology (ASCO) to be held in Chicago.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC